Clinical Trials Browser

Neuroblastoma

Adenoma, Islet Cell

Carcinoma, Ovarian Epithelial, Breast Neoplasms

Breast Neoplasms

Hematologic Diseases, Multiple Myeloma

Carcinoma, Intraductal, Noninfiltrating

Osteosarcoma

Neuroblastoma, Ganglioneuroblastoma

Pancreatic Neoplasms

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Lymphoma, Follicular

Prostatic Neoplasms

Uveal Melanoma, Melanoma

Melanoma, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis

Prostatic Neoplasms

Carcinoma, Renal Cell

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Graft vs Host Disease, Hematologic Neoplasms

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Breast Neoplasms, Carcinoma, Ductal, Breast

Neoplasm Metastasis, Sarcoma, Osteosarcoma

Neuroblastoma

Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

WOKVAC

Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Lymvac-2

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

GIPI

Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Biological Therapy in Treating Women With Stage IV Breast Cancer

Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Combination Chemotherapy in Treating Children With Neuroblastoma

Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas